Novel methods for therapeutic vaccination
CA 2345817 C · Owner: Gautam, Anand · Inventors: Gautam, Anand; Rasmussen, Peter Birk; Haaning, Jesper
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method is disclosed for inducing cell-mediated immunity against cellular antigens. More specifically, the invention provides for a method for inducing cytotoxic T-lymphocyte immunity against weak antigens notably self-proteins. , The method entails that antigen presenting cells are induced to present at least one CTL epitope of the weak antigen and at the same time presenting at least one foreign T-helper lymphocyte epitope. In a preferred embodiment the , antigen is a cancer specific antigen e.g. PSM, Her2, or FGF8b. The method can be exercised by using traditional polypeptide vaccination but also by using , live attenuated vaccines or nucleic acid vaccination. The invention …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 5, 1999 and granted February 12, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 5, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 5, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.